Galena Biopharma competitors

Galena Biopharma's competitors include CytomX Therapeutics, TESARO, AVEO Pharmaceuticals and Merrimack Pharmaceuticals
Add company...
Galena Biopharma
Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics.
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Founding Date
Founding Date
2003
Founding Date
2008
Founding Date
2010
Founding Date
2001
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Portland, US HQ
Locations
South San Francisco, US HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Employees
Employees
14
Employees
78
Employees
446
Employees
20
Employees
294
Valuation ($)
Valuation ($)
11.1 m
Valuation ($)
1 b
Valuation ($)
1.5 b
Valuation ($)
276.1 m
Valuation ($)
68 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
445
Facebook likes
647
Twitter followers
Twitter followers
1 k
Twitter followers
385
Twitter followers
1.8 k
Twitter followers
650
Twitter followers
1.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$71.6m (FY, 2017)
Revenue (est.)
$223.3m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($23.8m) (FY, 2017)
Net income
($43.1m) (FY, 2017)
Net income
($496.1m) (FY, 2017)
Net income
($26.9m) (FY, 2016)
Net income
$470.9m (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 132.4m
Total funding raised
$ 161m
Total funding raised
$ 138.2m
Total funding raised
$ 79.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

CytomX Therapeutics
HQ
South San Francisco, US
Employees
78

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
20

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
294

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company